Published in J Nucl Med on August 01, 1991
Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation. Neuroimage (2007) 2.50
The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging. Prog Neurobiol (2006) 2.10
Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors. Neuroimage (2007) 1.91
Quantification of translocator protein (18 kDa) in the human brain with PET and a novel radioligand, (18)F-PBR06. J Nucl Med (2009) 1.36
Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide. J Nucl Med (2012) 1.12
Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline. J Nucl Med (2010) 1.05
Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography. J Cereb Blood Flow Metab (2011) 1.05
[18F]DPA-714: direct comparison with [11C]PK11195 in a model of cerebral ischemia in rats. PLoS One (2013) 1.00
The methodology of TSPO imaging with positron emission tomography. Biochem Soc Trans (2015) 0.96
The translocator protein ligand [¹⁸F]DPA-714 images glioma and activated microglia in vivo. Eur J Nucl Med Mol Imaging (2012) 0.94
18F-GE-180: a novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke. Eur J Nucl Med Mol Imaging (2014) 0.92
Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary Study. PLoS One (2015) 0.86
[¹¹C]-(R)PK11195 tracer kinetics in the brain of glioma patients and a comparison of two referencing approaches. Eur J Nucl Med Mol Imaging (2013) 0.85
A Novel PET Imaging Probe for the Detection and Monitoring of Translocator Protein 18 kDa Expression in Pathological Disorders. Sci Rep (2016) 0.84
TSPO PET for glioma imaging using the novel ligand (18)F-GE-180: first results in patients with glioblastoma. Eur J Nucl Med Mol Imaging (2017) 0.78
TSPO 18 kDa (PBR) Targeted Photosensitizers for Cancer Imaging (PET) and PDT. ACS Med Chem Lett (2010) 0.77
Affinity labeling of membrane receptors using tissue-penetrating radiations. Biomed Res Int (2013) 0.75
Positron emission tomography and the central nervous system. Arch Dis Child (1999) 0.75
TSPO expression in brain tumours: is TSPO a target for brain tumour imaging? Clin Transl Imaging (2016) 0.75
TSPO PET using (18)F-GE-180: a new perspective in neurooncology? Eur J Nucl Med Mol Imaging (2017) 0.75
Golgi apparatus, GERL, and lysosomes of neurons in rat dorsal root ganglia, studied by thick section and thin section cytochemistry. J Cell Biol (1971) 5.94
Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med (1999) 4.79
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood (2001) 3.93
Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science (1997) 3.68
Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry (2002) 3.41
Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology (2006) 2.90
Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol (1996) 2.68
Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke (2000) 2.59
Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology (2007) 2.52
False-negative diffusion-weighted MR findings in acute ischemic stroke. AJNR Am J Neuroradiol (2000) 2.42
Large amounts of neocortical beta A4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person. Neurosci Lett (1990) 2.40
Primary central nervous system lymphomas in 72 immunocompetent patients: pathologic findings and clinical correlations. Groupe Ouest Est d'étude des Leucénies et Autres Maladies du Sang (GOELAMS) Am J Clin Pathol (1998) 2.35
BSE transmission to macaques. Nature (1996) 2.32
Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg (2000) 2.25
Sporadic Creutzfeldt-Jakob disease mimicking nonconvulsive status epilepticus. Neurology (2010) 2.17
Detection of paroxysmal atrial fibrillation with transtelephonic EKG in TIA or stroke patients. Neurology (2010) 2.14
The cortical representation of speech. J Cogn Neurosci (1993) 2.12
Paramedian thalamic and midbrain infarct: clinical and neuropathological study. Ann Neurol (1981) 2.10
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol (1995) 2.10
Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry (2005) 2.08
Thrombolysis in cervical artery dissection--data from the Cervical Artery Dissection and Ischaemic Stroke Patients (CADISP) database. Eur J Neurol (2012) 2.07
Concept of reaction volume in the in vivo ligand-receptor model. J Nucl Med (1996) 2.01
Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol (2004) 1.97
Rating of the lesions in senile dementia of the Alzheimer type: concordance between laboratories. A European multicenter study under the auspices of EURAGE. J Neurol Sci (1990) 1.96
[Anatomy of the cerebellar arteries]. Rev Neurol (Paris) (1989) 1.96
Diffusion-weighted MRI in acute stroke within the first 6 hours: 1.5 or 3.0 Tesla? Neurology (2010) 1.94
Superior temporal sulcus anatomical abnormalities in childhood autism: a voxel-based morphometry MRI study. Neuroimage (2004) 1.93
Left prefrontal glucose hypometabolism in the depressed state: a confirmation. Am J Psychiatry (1990) 1.92
Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med (1999) 1.91
Does amyloid precede paired helical filaments in the senile plaque? A study of 15 cases with graded intellectual status in aging and Alzheimer disease. Neurosci Lett (1988) 1.89
Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia (2000) 1.88
Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases) Brain Pathol (1995) 1.86
Neural substrates for the perception of acutely induced dyspnea. Am J Respir Crit Care Med (2001) 1.86
Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc Natl Acad Sci U S A (1998) 1.85
Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur J Pharmacol (1991) 1.85
Peduncular 'rubral' tremor and dopaminergic denervation: a PET study. Neurology (1995) 1.84
Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects. Neurology (2004) 1.82
The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med (1992) 1.80
Visual word recognition in the left and right hemispheres: anatomical and functional correlates of peripheral alexias. Cereb Cortex (2003) 1.79
Recovery from nonfluent aphasia after melodic intonation therapy: a PET study. Neurology (1996) 1.73
Effects of thalamic stroke on energy metabolism of the cerebral cortex. A positron tomography study in man. Brain (1986) 1.70
Pallidal stimulation for Parkinson's disease. Two targets? Neurology (1997) 1.69
Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res (1983) 1.67
Positron emission tomography with 11C CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy. Circulation (1993) 1.62
Tourette's syndrome and deep brain stimulation. J Neurol Neurosurg Psychiatry (2005) 1.60
Cytoarchitectonic alterations in the supramarginal gyrus of late onset Alzheimer's disease. Acta Neuropathol (1998) 1.59
Lateralization of speech and auditory temporal processing. J Cogn Neurosci (1998) 1.58
Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995). Leukemia (2000) 1.58
Crossed cerebellar diaschisis. Further studies. Brain (1986) 1.56
HIV-1-associated cognitive/motor complex: absence of neuronal loss in the cerebral neocortex. Neurology (1993) 1.56
Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy. J Nucl Med (2001) 1.55
Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD. Neurology (2000) 1.55
Is there an apparent diffusion coefficient threshold in predicting tissue viability in hyperacute stroke? Stroke (2001) 1.53
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry (2009) 1.51
Early and delayed MR and PET changes after selective temporomesial radiosurgery in mesial temporal lobe epilepsy. AJNR Am J Neuroradiol (1999) 1.49
Canine myocardial beta-adrenergic, muscarinic receptor densities after denervation: a PET study. J Nucl Med (1995) 1.47
Noninvasive quantification of muscarinic receptors in vivo with positron emission tomography in the dog heart. Circulation (1990) 1.47
Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology (2000) 1.47
Brainstem gliomas in adults: prognostic factors and classification. Brain (2001) 1.46
Reliability of the ECASS radiological classification of postthrombolysis brain haemorrhage: a comparison of CT and three MRI sequences. Cerebrovasc Dis (2010) 1.46
Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-- Jakob disease: implications for human health. Proc Natl Acad Sci U S A (2001) 1.46
Exercise-induced muscle modifications: study of healthy subjects and patients with metabolic myopathies with MR imaging and P-31 spectroscopy. Radiology (1991) 1.46
Sporadic CJD clinically mimicking variant CJD with bilateral increased signal in the pulvinar. Neurology (2002) 1.43
[Cerebral tropical malaria with blackwater fever. A current diagnostic and therapeutic problem]. Schweiz Med Wochenschr (1974) 1.41
Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. J Pharmacol Exp Ther (1997) 1.41
Microfluidic reactor for the radiosynthesis of PET radiotracers. Appl Radiat Isot (2005) 1.40
Evidence for, and nature of, the tonic inhibitory influence of habenulointerpeduncular pathways upon cerebral dopaminergic transmission in the rat. Brain Res (1986) 1.39
Amoxycillin/clavulanic acid prophylaxis in elective colorectal surgery: a prospective randomized trial. J Hosp Infect (1997) 1.39
Prevalence, incidence and duration of Braak's stages in the general population: can we know? Neurobiol Aging (1997) 1.39
Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain (2002) 1.38
Frontal dysfunction in neurologically normal chronic alcoholic subjects: metabolic and neuropsychological findings. Psychol Med (1998) 1.38
Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates. Neurology (2000) 1.36
Correspondence between functional magnetic resonance imaging somatotopy and individual brain anatomy of the central region: comparison with intraoperative stimulation in patients with brain tumors. J Neurosurg (2000) 1.35
Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients: a positron tomography study. J Cereb Blood Flow Metab (1984) 1.35
Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J Neuroimmunol (1993) 1.33
Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies. Life Sci (1983) 1.31
[Amiodaron neuropathy: clinical and pathological study of a new drug induced lipidosis (author's transl)]. Rev Neurol (Paris) (1980) 1.31
Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type. Acta Neuropathol (1986) 1.29
Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J Neuropathol Exp Neurol (1990) 1.29
Fatal familial insomnia: clinical and pathologic study of five new cases. Neurology (1992) 1.29
Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol (1991) 1.28
The right brain hemisphere is dominant in human infants. Brain (1997) 1.27
Aggressive behavior induced by intraoperative stimulation in the triangle of Sano. Neurology (2002) 1.27
Dopaminergic and cholinergic lesions in progressive supranuclear palsy. Ann Neurol (1985) 1.26
Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy. Brain (1985) 1.26
Delayed maturation of the frontal cortex in childhood autism. Am J Psychiatry (1995) 1.26
Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]RO5-4864 and [3H]PK 11195, by thermodynamic studies. Life Sci (1983) 1.25
Movement- and task-related activations of motor cortical areas: a positron emission tomographic study. Ann Neurol (1994) 1.24